These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 17850374

  • 1. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
    Gallina A, Briganti A, Chun FK, Walz J, Hutterer GC, Erbersdobler A, Eichelberg C, Schlomm T, Ahyai SA, Perrotte P, Saad F, Montorsi F, Huland H, Graefen M, Karakiewicz PI.
    BJU Int; 2007 Dec; 100(6):1249-53. PubMed ID: 17850374
    [Abstract] [Full Text] [Related]

  • 2. Visual estimation of tumour extent is not an independent predictor of prostate specific antigen recurrence.
    Jones TD, Koch MO, Lin H, Cheng L.
    BJU Int; 2005 Dec; 96(9):1253-7. PubMed ID: 16287440
    [Abstract] [Full Text] [Related]

  • 3. Lymphovascular invasion in prostate cancer: prognostic significance in patients treated with radiotherapy after radical prostatectomy.
    Brooks JP, Albert PS, O'Connell J, McLeod DG, Poggi MM.
    Cancer; 2006 Apr 01; 106(7):1521-6. PubMed ID: 16518811
    [Abstract] [Full Text] [Related]

  • 4. Does the time from biopsy to surgery affect biochemical recurrence after radical prostatectomy?
    Boorjian SA, Bianco FJ, Scardino PT, Eastham JA.
    BJU Int; 2005 Oct 01; 96(6):773-6. PubMed ID: 16153197
    [Abstract] [Full Text] [Related]

  • 5. Race and prostate weight as independent predictors for biochemical recurrence after radical prostatectomy.
    Schroeck FR, Sun L, Freedland SJ, Jayachandran J, Robertson CN, Moul JW.
    Prostate Cancer Prostatic Dis; 2008 Oct 01; 11(4):371-6. PubMed ID: 18427570
    [Abstract] [Full Text] [Related]

  • 6. Site of positive surgical margins influences biochemical recurrence after radical prostatectomy.
    Godoy G, Tareen BU, Lepor H.
    BJU Int; 2009 Dec 01; 104(11):1610-4. PubMed ID: 19549257
    [Abstract] [Full Text] [Related]

  • 7. Cancer-specific survival and predictors of prostate-specific antigen recurrence and survival in patients with seminal vesicle invasion after radical prostatectomy.
    Secin FP, Bianco FJ, Vickers AJ, Reuter V, Wheeler T, Fearn PA, Eastham JA, Scardino PT.
    Cancer; 2006 Jun 01; 106(11):2369-75. PubMed ID: 16649221
    [Abstract] [Full Text] [Related]

  • 8. Importance of tumor location in patients with high preoperative prostate specific antigen levels (greater than 20 ng/ml) treated with radical prostatectomy.
    Magheli A, Rais-Bahrami S, Peck HJ, Walsh PC, Epstein JI, Trock BJ, Gonzalgo ML.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1311-5. PubMed ID: 17698095
    [Abstract] [Full Text] [Related]

  • 9. Subclassification of clinical stage T1 prostate cancer: impact on biochemical recurrence following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Carter HB, Peck HJ, Epstein JI, Gonzalgo ML.
    J Urol; 2007 Oct 01; 178(4 Pt 1):1277-80; discussion 1280-1. PubMed ID: 17698121
    [Abstract] [Full Text] [Related]

  • 10. Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
    Chun FK, Briganti A, Antebi E, Graefen M, Currlin E, Steuber T, Schlomm T, Walz J, Haese A, Friedrich MG, Ahyai SA, Eichelberg C, Salomon G, Gallina A, Erbersdobler A, Perrotte P, Heinzer H, Huland H, Karakiewicz PI.
    BJU Int; 2006 Dec 01; 98(6):1204-9. PubMed ID: 17034506
    [Abstract] [Full Text] [Related]

  • 11. Health-insurance status is a determinant of the stage at presentation and of cancer control in European men treated with radical prostatectomy for clinically localized prostate cancer.
    Gallina A, Karakiewicz PI, Chun FK, Briganti A, Graefen M, Montorsi F, Walz J, Jeldres C, Erbersdobler A, Salonia A, Suardi N, Dehò F, Schlomm T, Scattoni V, Haese A, Heinzer H, Valiquette L, Rigatti P, Huland H.
    BJU Int; 2007 Jun 01; 99(6):1404-8. PubMed ID: 17428250
    [Abstract] [Full Text] [Related]

  • 12. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML.
    J Urol; 2007 Nov 01; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [Abstract] [Full Text] [Related]

  • 13. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.
    Suardi N, Porter CR, Reuther AM, Walz J, Kodama K, Gibbons RP, Correa R, Montorsi F, Graefen M, Huland H, Klein EA, Karakiewicz PI.
    Cancer; 2008 Mar 15; 112(6):1254-63. PubMed ID: 18286530
    [Abstract] [Full Text] [Related]

  • 14. Radical prostatectomy for clinically localized, high risk prostate cancer: critical analysis of risk assessment methods.
    Yossepowitch O, Eggener SE, Bianco FJ, Carver BS, Serio A, Scardino PT, Eastham JA.
    J Urol; 2007 Aug 15; 178(2):493-9; discussion 499. PubMed ID: 17561152
    [Abstract] [Full Text] [Related]

  • 15. High-grade prostatic intraepithelial neoplasia is an independent predictor of outcome after radical prostatectomy.
    Pierorazio PM, Lambert SM, Matsukhani M, Sprenkle PC, McCann TR, Katz AE, Olsson CA, Benson MC, McKiernan JM.
    BJU Int; 2007 Nov 15; 100(5):1066-70. PubMed ID: 17784880
    [Abstract] [Full Text] [Related]

  • 16. Long-term biochemical recurrence rates after robot-assisted radical prostatectomy: analysis of a single-center series of patients with a minimum follow-up of 5 years.
    Suardi N, Ficarra V, Willemsen P, De Wil P, Gallina A, De Naeyer G, Schatteman P, Montorsi F, Carpentier P, Mottrie A.
    Urology; 2012 Jan 15; 79(1):133-8. PubMed ID: 22088567
    [Abstract] [Full Text] [Related]

  • 17. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer.
    Fradet V, Lessard L, Bégin LR, Karakiewicz P, Masson AM, Saad F.
    Clin Cancer Res; 2004 Dec 15; 10(24):8460-4. PubMed ID: 15623625
    [Abstract] [Full Text] [Related]

  • 18. Risk-adjusted hazard rates of biochemical recurrence for prostate cancer patients after radical prostatectomy.
    Walz J, Chun FK, Klein EA, Reuther A, Graefen M, Huland H, Karakiewicz PI.
    Eur Urol; 2009 Feb 15; 55(2):412-19. PubMed ID: 19027223
    [Abstract] [Full Text] [Related]

  • 19. The impact of the extent of lymph-node dissection on biochemical relapse after radical prostatectomy in node-negative patients.
    Schiavina R, Bertaccini A, Franceschelli A, Manferrari F, Vagnoni V, Borghesi M, Morselli-Labate AM, Martorana G.
    Anticancer Res; 2010 Jun 15; 30(6):2297-302. PubMed ID: 20651383
    [Abstract] [Full Text] [Related]

  • 20. Impact of prostate-specific antigen testing on the clinical and pathological outcomes after radical prostatectomy for Gleason 8-10 cancers.
    Boorjian SA, Karnes RJ, Rangel LJ, Bergstralh EJ, Frank I, Blute ML.
    BJU Int; 2008 Feb 15; 101(3):299-304. PubMed ID: 17922854
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.